During the past decade, Yun chun Chen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Yun chun Chen" are "Depression" (1 trials) and "Schizophrenia" (1 trials). Many other conditions were trialed in "Yun chun Chen" in a lesser frequency.

Most popular intervention types in "Yun chun Chen" are "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "active Risperidone and active rTMS" (1 trials), "active rTMS and active Venlafaxine" (1 trials), "active rTMS and sham Risperidone" (1 trials), "active rTMS and sham Venlafaxine" (1 trials) and "sham rTMS and active Risperidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yun chun Chen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Yun chun Chen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Yun chun Chen, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yun chun Chen, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".